-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Tenax Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
- Tenax Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
- Tenax Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $6.57K, a 53.3% increase year-over-year.
- Tenax Therapeutics, Inc. annual Depreciation for 2023 was $7.57K, a 47.2% increase from 2022.
- Tenax Therapeutics, Inc. annual Depreciation for 2022 was $5.14K, a 25% increase from 2021.
- Tenax Therapeutics, Inc. annual Depreciation for 2021 was $4.12K, a 0.96% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)